Clinical Trial Update: Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial tested safety and preliminary efficacy of gene-modified neuroblastoma cells in relapsed/refractory neuroblastoma. The study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Gene-modified neuroblastoma cell therapy (gene-modified neuroblastoma cells)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED